Trial Profile
BCX4161, a First in Human study utilising a Translational Pharmaceutics Platform
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Oct 2017
Price :
$35
*
At a glance
- Drugs Avoralstat (Primary)
- Indications Hereditary angioedema
- Focus Adverse reactions; First in man; Pharmacokinetics
- Sponsors BioCryst Pharmaceuticals
- 16 Sep 2015 New trial record